EUVIMEDEUVIMED entdecken
Crossref

Effects of injectable platelet-rich fibrin (i-PRF) on pterygium surgery with conjunctival autograft

Alperen Bahar, Huri Sabur

International Ophthalmology · 2024

DOI: 10.1007/s10792-024-02920-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Ophthalmology, 2024. Verfasst von Alperen Bahar und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophtalmology, Diskapi Yıldırım Beyazıt Training and Research Hospital, Ankara, Turkey. alperenbahar@hotmail.com. Hauptthemen laut MEDLINE: Pterygium, Platelet-Rich Fibrin. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

OBJECTIVES: To investigate the effects of subconjunctival injectable platelet-rich fibrin (i-PRF) injection on healing and complication rates after pterygium surgery with conjunctival autograft. METHODS: This retrospective and comparative study evaluated 31 eyes that received i-PRF injections under the donor and graft conjunctiva following pterygium surgery, while 34 eyes did not receive i-PRF after the pterygium surgery. The patients' follow-up period was for 12 months. Postoperative recurrence, epithelial healing time, postoperative pain score, graft edema, and sliding of the graft (need for re-suturation) data were evaluated. RESULTS: For the 12 months after surgery, one eye (3.2%) in the i-PRF group had developed corneal recurrence, and five eyes (14.7%) in the non-i-PRF group had developed recurrence. The mean corneal epithelial healing time was 2.96 ± 0.70 days in the i-PRF group and 3.58 ± 0.70 days in the non-i-PRF group (p = 0.001). The mean healing time of the donor conjunctiva epithelium was 3.84 ± 0.70 days in the i-PRF group, whereas it was 4.44 ± 0.74 days in the non-i-PRF group (p = 0.006). The mean postoperative pain score was 4.45 ± 1.52 in the i-PRF group and 5.08 ± 1.40 in the non-i-PRF group. In the non-i-PRF group, three cases (8.8%) required re-suturation, whereas, in the i-PRF group, no one required re-suturation. CONCLUSIONS: Thanks to its platelets-derived growth factors, i-PRF can be a safe and effective adjuvant therapy for faster healing of conjunctival autograft and in the prevention of recurrence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PterygiumPlatelet-Rich FibrinHumansAutograftsRetrospective StudiesTreatment OutcomeFollow-Up StudiesConjunctivaTransplantation, AutologousPostoperative PainRecurrencePostoperative Complications

Stichwörter der Autor:innen

Conjunctival autograftPterygiumi-PRF

Autor:innen und Institutionen

  • Department of Ophtalmology, Diskapi Yıldırım Beyazıt Training and Research Hospital, Ankara, Turkey. alperenbahar@hotmail.com.
  • Department of Ophtalmology, Diskapi Yıldırım Beyazıt Training and Research Hospital, Ankara, Turkey.

Zitieren

APA

Bahar, A., & Sabur, H. (2024). Effects of injectable platelet-rich fibrin (i-PRF) on pterygium surgery with conjunctival autograft. International Ophthalmology. https://doi.org/10.1007/s10792-024-02920-5

Vancouver

Bahar A, Sabur H. Effects of injectable platelet-rich fibrin (i-PRF) on pterygium surgery with conjunctival autograft. International Ophthalmology. 2024. doi:10.1007/s10792-024-02920-5

BibTeX
@article{Bahar2024,
  author = {Bahar, Alperen and Sabur, Huri},
  title = {Effects of injectable platelet-rich fibrin (i-PRF) on pterygium surgery with conjunctival autograft},
  journal = {International Ophthalmology},
  year = {2024},
  doi = {10.1007/s10792-024-02920-5}
}
Kostenlos starten →